Chinese Fibromyalgia Market Research Report By Diagnosis (Laboratory Evaluation, Presence Of Central Sensitization), Treatment (Targeted (Antidepressants, Anti-Seizure Drugs), Symptomatic Treatment, End Users (Hospitals &Clinics) - Forecast Till 2032

1 Report Prologue

2 Market Introduction

2.1 Research Objective 12

2.2 Assumptions & Limitations 12

2.2.1 Assumptions 12

2.2.2 Limitations 12

3 Research Methodology

3.1 Research Process 14

3.2 Primary Research 15

3.3 Secondary Research 15

3.4 Market Size Estimation 15

4 Market Dynamics

4.1 Introduction 18

4.2 Drivers 19

4.2.1 Rising Incidences of Traumatic Stress and Road Accidents 19

4.2.2 Increasing Cases of Rheumatic Diseases 20

4.2.3 Growing Awareness among the population 21

4.2.4 Increasing geriatric population 22

4.3 Restraints 23

4.3.1 Difficulty in Diagnosis 23

4.4 Opportunities 24

4.4.1 Unmet Medical Need in Fibromyalgia Treatment 24

4.5 Mega Trends 24

4.5.1 Chinese Treatment Options 24

4.5.2 Pipeline Drugs 24

4.5.2.1 ASP8062 24

4.5.2.2 ASP0819 24

4.5.2.3 IMC-1 25

4.6 Macroeconomic Indicators 25

5 Market Factor Analysis

5.1 Value Chain Analysis 27

5.1.1 R&D 27

5.1.2 Manufacturing 27

5.1.3 Distribution & Sales 27

5.1.4 Post-Sales Monitoring 28

5.2 Porter’s Five Forces Model 28

5.2.1 Bargaining Power of Suppliers 29

5.2.2 Bargaining Power of Buyers 29

5.2.3 Threat of New Entrant 29

5.2.4 Threat of Substitute 29

5.2.5 Intensity of Rivalry 29

5.3 Demand & Supply: Gap Analysis 30

5.4 Pricing Analysis 30

5.5 Investment Opportunity Analysis 30

6 Chinese Fibromyalgia Market, By Diagnosis

6.1 Introduction 32

6.2 Laboratory Evaluation 33

6.3 Presence of Central Sensitization 34

7 Global and China Fibromyalgia Market, By Treatment

7.1 Introduction 36

7.2 Introduction 37

7.3 Targeted Treatment 38

7.4 Symptomatic treatment 39

8 Chinese Fibromyalgia Market, By End Users

8.1 Introduction 41

8.2 Hospitals 42

8.3 Clinics 42

8.4 Diagnostic Centers 43

9 Chinese Fibromyalgia Market, By Regions

9.1 Introduction 45

9.2 North China 46

9.3 Northwest China 47

9.4 East China 49

9.5 South Central China 50

9.6 South West China 52

10 Competitive landscape

10.1 Introduction 55

11 Company Profiles

11.1 Pfizer 57

11.1.1 Financials 57

11.1.2 Products 57

11.1.3 Strategy 57

11.1.4 Key Developments 57

11.2 GlaxoSmithKline 58

11.2.1 Financials 58

11.2.2 Products 58

11.2.3 Strategy 58

11.2.4 Key Developments 58

11.3 AstraZeneca 59

11.3.1 Financials 59

11.3.2 Products 59

11.3.3 Strategy 59

11.3.4 Key Developments 59

11.4 Roche 60

11.4.1 Financials 60

11.4.2 Products 60

11.4.3 Strategy 60

11.4.4 Key Developments 60

11.5 Astellas Pharma 61

11.5.1 Financials 61

11.5.2 Products 61

11.5.3 Strategy 61

11.5.4 Key Developments 61

11.6 Eli Lilly and Company 62

11.6.1 Financials 62

11.6.2 Products 62

11.6.3 Strategy 62

11.6.4 Key Developments 62

11.7 Johnson & Johnson 63

11.7.1 Financials 63

11.7.2 Products 63

11.7.3 Strategy 63

11.7.4 Key Developments 63

11.8 SANOFI 64

11.8.1 Financials 64

11.8.2 Products 64

11.8.3 Strategy 64

11.8.4 Key Developments 64

11.9 Bayer 65

11.9.1 Financials 65

11.9.2 Products 65

11.9.3 Strategy 65

11.9.4 Key Developments 65

11.10 AbbVie 66

11.10.1 Financials 66

11.10.2 Products 66

11.10.3 Strategy 66

11.10.4 Key Developments 66

11.11 ALLERGAN 67

11.11.1 Financials 67

11.11.2 Products 67

11.11.3 Strategy 67

11.11.4 Key Developments 67

12 Conclusion

12.1 Key Findings 69

12.1.1 From CEO’s View Point 69

12.2 Key companies to watch 69

13 Appendix

13.1 Discussion Blue Print 71

14 List of Tables

TABLE 1 MARKET SYNOPSIS 10

TABLE 2 CHINESE FIBROMYALGIA MARKET, BY DIAGNOSIS 2023-2030 (USD MILLION) 32

TABLE 3 CHINESE FIBROMYALGIA MARKET FOR LABORATORY EVALUATION 2023-2030 (USD MILLION) 33

TABLE 4 CHINESE FIBROMYALGIA MARKET FOR PRESENCE OF CENTRAL SENSITIZATION 2023-2030 (USD MILLION) 34

TABLE 5 GLOBAL FIBROMYALGIA MARKET, BY TREATMENT 2023-2030 (USD MILLION) 36

TABLE 6 CHINESE FIBROMYALGIA MARKET, BY TREATMENT 2023-2030 (USD MILLION) 37

TABLE 7 CHINESE FIBROMYALGIA MARKET FOR TARGETED TREATMENT 2023-2030 (USD MILLION) 38

TABLE 8 CHINESE FIBROMYALGIA MARKET FOR SYMPTOMATIC TREATMENT 2023-2030 (USD MILLION) 39

TABLE 9 CHINESE FIBROMYALGIA MARKET, BY END USER 2023-2030 (USD MILLION) 41

TABLE 10 CHINESE FIBROMYALGIA MARKET FOR HOSPITALS 2023-2030 (USD MILLION) 42

TABLE 11 CHINESE FIBROMYALGIA MARKET FOR CLINICS 2023-2030 (USD MILLION) 42

TABLE 12 CHINESE FIBROMYALGIA MARKET FOR DIAGNOSTIC CENTERS 2023-2030 (USD MILLION) 43

TABLE 13 CHINESE FIBROMYALGIA MARKET, BY REGIONS 2023-2030 (USD MILLION) 45

TABLE 14 NORTH CHINA CHINESE FIBROMYALGIA MARKET, BY DIAGNOSIS 2023-2030 (USD MILLION) 46

TABLE 15 NORTH CHINA CHINESE FIBROMYALGIA MARKET, BY TREATMENT 2023-2030 (USD MILLION) 46

TABLE 16 NORTH CHINA CHINESE FIBROMYALGIA MARKET, BY END USER 2023-2030 (USD MILLION) 47

TABLE 17 NORTHWEST CHINA CHINESE FIBROMYALGIA MARKET, BY DIAGNOSIS 2023-2030 (USD MILLION) 47

TABLE 18 NORTHWEST CHINA CHINESE FIBROMYALGIA MARKET, BY TREATMENT 2023-2030 (USD MILLION) 48

TABLE 19 NORTHWEST CHINA CHINESE FIBROMYALGIA MARKET, BY END USER 2023-2030 (USD MILLION) 48

TABLE 20 EAST CHINA CHINESE FIBROMYALGIA MARKET, BY DIAGNOSIS 2023-2030 (USD MILLION) 49

TABLE 21 EAST CHINA CHINESE FIBROMYALGIA MARKET, BY TREATMENT 2023-2030 (USD MILLION) 49

TABLE 22 EAST CHINA CHINESE FIBROMYALGIA MARKET, BY END USER 2023-2030 (USD MILLION) 50

TABLE 23 SOUTH CENTRAL CHINA CHINESE FIBROMYALGIA MARKET, BY DIAGNOSIS 2023-2030 (USD MILLION) 50

TABLE 24 SOUTH CENTRAL CHINA CHINESE FIBROMYALGIA MARKET, BY TREATMENT 2023-2030 (USD MILLION) 51

TABLE 25 SOUTH CENTRAL CHINA CHINESE FIBROMYALGIA MARKET, BY END USER 2023-2030 (USD MILLION) 51

TABLE 26 SOUTH WEST CHINA CHINESE FIBROMYALGIA MARKET, BY DIAGNOSIS 2023-2030 (USD MILLION) 52

TABLE 27 SOUTH WEST CHINA CHINESE FIBROMYALGIA MARKET, BY TREATMENT 2023-2030 (USD MILLION) 52

TABLE 28 SOUTH WEST CHINA CHINESE FIBROMYALGIA MARKET, BY END USER 2023-2030 (USD MILLION) 53

15 List of Figures

FIGURE 1 MARKET STRUCTURE 12

FIGURE 2 RESEARCH PROCESS 14

FIGURE 3 VALUE CHAIN: CHINESE FIBROMYALGIA MARKET 27

FIGURE 4 PORTERS FIVE FORCES ANALYSIS: CHINESE FIBROMYALGIA MARKET 28

FIGURE 5 CHINESE FIBROMYALGIA MARKET, BY DIAGNOSIS 2023 & 2030 (USD MILLION) 33

FIGURE 6 GLOBAL FIBROMYALGIA MARKET, BY TREATMENT 2023 & 2030 (USD MILLION) 36

FIGURE 7 CHINESE FIBROMYALGIA MARKET, BY TREATMENT 2023 & 2030 (USD MILLION) 38

FIGURE 8 CHINESE FIBROMYALGIA MARKET, BY END USER 2023 & 2030 (USD MILLION) 41

FIGURE 9 CHINA FIBROMYALGIA MARKET SHARE, BY REGION MARKET, 2023 (%) 45

FIGURE 10 CHINA FIBROMYALGIA MARKET SHARE ANALYSIS, 2023 (%) 55